Fluidigm (NASDAQ:FLDM) Latest News, Stock Price and Trading Information

Fluidigm Announces Conference Call and Webcast of First Quarter 2019 Financial Results

Globe Newswire 4-Apr 4:05 PM

Recent Analysis Shows Newell Brands, NorthStar Realty Europe, Advanced Disposal Services, Fluidigm, Huron Consulting Group, and Healthcare Realty Trust Market Influences Renewed Outlook, Key Drivers of Growth

Globe Newswire 3-Apr 7:45 AM

Fluidigm Showcases New Product Innovations and Research Presentations at the 2019 American Association for Cancer Research (AACR) Meeting

Globe Newswire 28-Mar 8:45 AM

Fluidigm Introduces the First Complete Sample-to-Answer Solution for Deep Immune Profiling by Mass Cytometry

Globe Newswire 28-Mar 8:31 AM

Colin McCracken Joins Fluidigm as Chief Commercial Officer

Globe Newswire 5-Mar 8:30 AM

Fluidigm to Participate in Upcoming Investor Conferences

Globe Newswire 22-Feb 5:31 PM

Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Globe Newswire 12-Feb 7:00 PM

Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results

Globe Newswire 7-Feb 4:05 PM

Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations

Globe Newswire 7-Feb 9:00 AM

Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases

Globe Newswire 7-Feb 8:30 AM

Fluidigm Introduces REAP-Seq for Multi-Omic Single-Cell Analysis on the C1

Globe Newswire 31-Jan 8:30 AM

Consolidated Research: 2019 Summary Expectations for Marriott International, Calavo Growers, Kinsale Capital Group, Fluidigm, Goldman Sachs BDC, and Stemline Therapeutics Fundamental Analysis, Key Performance Indications

Globe Newswire 24-Jan 7:55 AM